Navigation Links
Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years

BETHESDA, Md., March 27, 2007--A new study shows that as rates of diabetes have risen in the U.S., the proportion of cardiovascular disease (CVD) linked to diabetes has also increased.

These findings emphasize the need for increased efforts to prevent diabetes and to aggressively treat and control CVD risk factors among those with diabetes, according to the investigators from the long-standing Framingham Heart Study, a program of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

The researchers compared risk factors for cardiovascular disease and cardiovascular “events” such as heart attacks in Framingham study participants from two different time periods. The first group was examined between 1952 and 1974 and the more recent group was examined between 1975 and 1998. A total of 9,540 individuals age 45 to 64 were evaluated. The risk attributable to diabetes was 5.2 percent in the earlier time period, compared to 7.8 percent in the later period. Most of the increased risk was observed among men. The scientists also reported that the prevalence of diabetes among those with CVD almost doubled between the earlier and later time periods and there was also an increase in the prevalence of obesity.

“Increasing Cardiovascular Burden Due to Diabetes: the Framingham Heart Study” is published in the March 27th issue of Circulation and is also currently available online (March 12 Rapid Access issue).

Caroline Fox, M.D., lead author and medical officer with the Framingham Heart Study of NHLBI, is available to comment on the study’s findings. She can discuss reasons for the increased burden of cardiovascular disease due to diabetes and the need to aggressively treat and control cardiovascular disease risk factors in people with diabetes.

To schedule interviews with Dr. Fox, contact the NHLBI Communications Office at 301
'"/>




Page: 1 2 3

Related medicine technology :

1. Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. Phase IIIb Clinical Data Validate the Overall and Cardiovascular Safety Profile of Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) in Patients with Type 2 Diabetes
4. Byetta Treatment for Three and a Half Years Associated with Reductions in Cardiovascular Risk Factors in People with Type 2 Diabetes
5. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
6. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur
7. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
8. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
9. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
10. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
11. New Data Show Xenical Significantly Reduces Cardiovascular Risk and More Than Doubles Weight Loss Achieved in Overweight and Obese People
Post Your Comments:
(Date:1/22/2015)...  Bio-Techne Corporation (NASDAQ: TECH ) announced today ... the new Simple Plex platform through its Proteins Platform ... re-branding of the previously acquired CyPlex instrument platform from ... transformative immunoassay technology which integrates an innovatively designed microfluidic ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... of the "Infectious Disease Diagnostics Market by Product, ... report to their offering. , The ... CAGR of 7.9% to reach $18,156.2 million by 2019 ...
(Date:1/22/2015)... The Parenteral Drug Association (PDA) today announced the launch ... Pharmaceutical Manufacturing,s Future. The Manufacturing Science ... , Highlight the ongoing focus PDA has on pharmaceutical and ... filling known gaps in current manufacturing science as well as ...
Breaking Medicine Technology:Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3PDA Launches Manufacturing Science Program(SM) 2PDA Launches Manufacturing Science Program(SM) 3
... MedImmune today announced,that it has initiated a Phase ... healthy children one month to 12 months of age ... is,the most common respiratory infection in infants and can ... is a serious respiratory disease that can have significant ...
... Meeting -, - Conference call to be hosted ... BRANFORD, Conn., Nov. 3 CuraGen Corporation,(Nasdaq: CRGN ... II,trial of CR011-vcMMAE, an antibody-drug conjugate that targets GPNMB, ... Stage IV melanoma.,Dr. Patrick Hwu, Co-Principal Investigator, and Professor ...
Cached Medicine Technology:MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7
(Date:1/22/2015)... Illinois (PRWEB) January 22, 2015 Deer Path ... will host a Valentine’s Day Happy Hour from 3 p.m. to ... at 12500 Regency Parkway in Huntley, Illinois, serves adults with physical ... Hour event will include Valentine's Day treats, games and sweetheart-themed karaoke. ...
(Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
(Date:1/22/2015)... January 23, 2015 VogueQueen is a seasoned ... prices and many designers are thrilled to have it lead ... announces its new collection of prom dresses for the global ... drive the strategic vision and he focuses on continuing the ...
(Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
(Date:1/22/2015)... York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo and ... federal multidistrict litigation underway in U.S. District Court, District ... Order dated January 20th, the Court has remanded a ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4
... the Florida-based processor of orthopedic, dental, hernia and other biologic implants, ... of RTI’s fresh-stored osteochondral (OC) allografts since its first implant in ... implants to repair cartilage damage, reducing their pain and returning them ... ...
... seeking to improve scientists, understanding of breast cancer, including why ... getting underway in 44 counties in North Carolina. , The ... Carolina state senator who died of breast cancer last year, ... the University of North Carolina at Chapel Hill. , The ...
... The College of,American Pathologists, a medical society serving ... throughout the world, today announced,that Charles Roussel has ... daily operations of the College and reporting to ... in transformational change, as well,as a passion for ...
... out for,the soccer team or training for a dance ... greater than adults. After all, they need,nutrition for growth ... from the foods they consume., Nutritious snacks that ... to,helping young athletes perform at their best. Portable snacks ...
... today announced it is,hosting a web seminar to ... requirements and leverage the same technology to improve,overall ... and recent,government enforcements to ensure security and data ... a top priority for many healthcare,organizations and this ...
... grow around nerves in a rare genetic disease need cooperation ... reports a team of scientists, including researchers from UT Southwestern ... the immune cells not the tumor greatly reduced ... A clinical trial of the treatment in humans has begun. ...
Cached Medicine News:Health News: RTI Biologics Sees Expanded Surgeon User Base of Fresh OC Allografts 2Health News: RTI Biologics Sees Expanded Surgeon User Base of Fresh OC Allografts 3Health News: RTI Biologics Sees Expanded Surgeon User Base of Fresh OC Allografts 4Health News:UNC Lineberger launches 44-county study of breast cancer in black women 2Health News:UNC Lineberger launches 44-county study of breast cancer in black women 3Health News:College of American Pathologists Selects Charles Roussel as Its New Executive Vice President 2Health News:Fueling Kids for Sports 2Health News:nCircle Announces Free Web Seminar - 'Automating HIPAA Compliance with Security & Configuration Auditing' 2Health News:Cancer requires support from immune system to develop, UT Southwestern researchers report 2Health News:Cancer requires support from immune system to develop, UT Southwestern researchers report 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: